Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.WT | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by bartlmanon Dec 24, 2020 3:08pm
200 Views
Post# 32181427

RE:RE:RE:RE:RE:RE:RE:Another therapeutic for COVID

RE:RE:RE:RE:RE:RE:RE:Another therapeutic for COVID Charlierock. I agree that 1433 being applied to Covid and other viruses is a very exciting notion. Now my understanding, based on what I read in the pr and newspaper article, was that they were about to begin an animal trial with 1433 being applied to the  the unsuspecting animals and hopefully not killing any of them. Supposing the animals are for the most part cured - dosing being the most important perameter - the next step would be human trials. I would imagine they'd start with small dosing and look at the effects on both the virus and the human. These kinds of trials could potentially take days - not even weeks or months - to assess. Now, the long range effects could take a longer range to figure out but if the consequence is a cured, virus free, undamaged human, the 1433 treatment could very well be fast-tracked.

And I'd like to add my Christmas best wishes to one and all and here's to a prosperous new year.
<< Previous
Bullboard Posts
Next >>